Inspirna, Inc.(formerly Rgenix, Inc.)
inspirna.comLocations
New York, NY, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series C+
founded in
2010
Inspirna (formerly Rgenix) is a clinical-stage biopharmaceutical company developing first-in-class/best-in-class drug candidates that target critical cancer drivers. Our discovery platform leverages RNA biology to discover novel RNA dysregulated cancer drivers that can be targeted by small molecules and biologics. Clinical programs are first-in-class oral small molecules in development for patients with RAS mutant CRC (RGX-202; Phase 1b) as well as SCLC and NSCLC (RGX-104; Phase 1b/2)
Something looks off?Open jobs at Inspirna, Inc.(formerly Rgenix, Inc.)
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.